Drugs / Ropren
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03122340 | Nov 2015 → Dec 2017 | acute coronary syndrome | Tomsk National Research Medical Center of the Russian Academy of Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ropren | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03122340 ↗ |
| Route | Oral | “Per os 8 drops 3 times per day for 3 weeks, then 5 drops 3 times per day for 5 weeks” NCT03122340 ↗ |